Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Personalis / 01-PS-001

Trial Overview

Official Title

Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I)

Study Purpose

Evaluate the correlation of Minimal Residual Disease detection by NeXT Personal CTA (a molecular test) to pathological Complete Response (pCR) after neoadjuvant chemotherapy (NAC) in stage I-III triple negative breast cancer (TNBC)

Diagnosis

Early stage 1-111 triple negative breast cancer

Eligibility

Documented early stage triple negative breast cancer not having started treatment

Intervention

Blood draw only

For more information, click the link below:

 

https://clinicaltrials.gov/study/NCT06230185?term=01-PS-001&rank=2

 

Key Participation Requirements
Trial Location(s)
Methodist Estabrook Cancer Center
Gender
male or female
Age
19 and older
Enrollment Status
Recruiting
Phase
Phase I
Methodist Health System Trial Code
01-PS-001